Pacific Biosciences of California, Inc. (PACB)
USD 1.19
(0.42%)
USD 1.19
(0.42%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.04 Billion USD | -13.24% |
| 2022 | 1.2 Billion USD | -0.97% |
| 2021 | 1.21 Billion USD | 1449.24% |
| 2020 | 78.48 Million USD | -15.66% |
| 2019 | 93.06 Million USD | 65.56% |
| 2018 | 56.21 Million USD | -3.05% |
| 2017 | 57.98 Million USD | 8.95% |
| 2016 | 53.21 Million USD | -7.56% |
| 2015 | 57.56 Million USD | -17.26% |
| 2014 | 69.57 Million USD | 3.83% |
| 2013 | 67 Million USD | 230.06% |
| 2012 | 20.3 Million USD | -24.4% |
| 2011 | 26.85 Million USD | 3.76% |
| 2010 | 25.88 Million USD | -90.7% |
| 2009 | 278.22 Million USD | 34.73% |
| 2008 | 206.49 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.02 Billion USD | -2.28% |
| 2024 Q2 | 1.01 Billion USD | -0.4% |
| 2023 FY | 1.04 Billion USD | -13.24% |
| 2023 Q2 | 1.2 Billion USD | 0.11% |
| 2023 Q3 | 1.13 Billion USD | -5.89% |
| 2023 Q4 | 1.04 Billion USD | -7.92% |
| 2023 Q1 | 1.2 Billion USD | 0.01% |
| 2022 Q3 | 1.19 Billion USD | -0.16% |
| 2022 Q4 | 1.2 Billion USD | 0.99% |
| 2022 FY | 1.2 Billion USD | -0.97% |
| 2022 Q1 | 1.2 Billion USD | -1.14% |
| 2022 Q2 | 1.19 Billion USD | -0.65% |
| 2021 Q2 | 987.53 Million USD | 1.56% |
| 2021 Q3 | 1.19 Billion USD | 20.84% |
| 2021 Q4 | 1.21 Billion USD | 1.9% |
| 2021 FY | 1.21 Billion USD | 1449.24% |
| 2021 Q1 | 972.33 Million USD | 1138.82% |
| 2020 Q3 | 170.82 Million USD | -0.83% |
| 2020 Q2 | 172.25 Million USD | -1.21% |
| 2020 Q1 | 174.36 Million USD | 87.35% |
| 2020 Q4 | 78.48 Million USD | -54.05% |
| 2020 FY | 78.48 Million USD | -15.66% |
| 2019 Q1 | 90.72 Million USD | 61.4% |
| 2019 Q3 | 95.09 Million USD | 0.28% |
| 2019 FY | 93.06 Million USD | 65.56% |
| 2019 Q4 | 93.06 Million USD | -2.13% |
| 2019 Q2 | 94.82 Million USD | 4.52% |
| 2018 Q4 | 56.21 Million USD | 10.17% |
| 2018 FY | 56.21 Million USD | -3.05% |
| 2018 Q3 | 51.02 Million USD | -1.08% |
| 2018 Q1 | 54.21 Million USD | -6.5% |
| 2018 Q2 | 51.58 Million USD | -4.85% |
| 2017 Q3 | 56.49 Million USD | -8.94% |
| 2017 FY | 57.98 Million USD | 8.95% |
| 2017 Q4 | 57.98 Million USD | 2.63% |
| 2017 Q1 | 66.32 Million USD | 24.63% |
| 2017 Q2 | 62.04 Million USD | -6.45% |
| 2016 Q3 | 51.95 Million USD | -2.53% |
| 2016 FY | 53.21 Million USD | -7.56% |
| 2016 Q1 | 51.39 Million USD | -10.71% |
| 2016 Q2 | 53.3 Million USD | 3.7% |
| 2016 Q4 | 53.21 Million USD | 2.43% |
| 2015 Q4 | 57.56 Million USD | -1.44% |
| 2015 Q2 | 62.93 Million USD | -4.57% |
| 2015 Q1 | 65.94 Million USD | -5.21% |
| 2015 FY | 57.56 Million USD | -17.26% |
| 2015 Q3 | 58.4 Million USD | -7.19% |
| 2014 Q4 | 69.57 Million USD | 1.41% |
| 2014 Q3 | 68.6 Million USD | -0.89% |
| 2014 Q2 | 69.22 Million USD | 5.66% |
| 2014 FY | 69.57 Million USD | 3.83% |
| 2014 Q1 | 65.51 Million USD | -2.22% |
| 2013 Q2 | 33.87 Million USD | 3.66% |
| 2013 Q4 | 67 Million USD | -3.25% |
| 2013 Q3 | 69.25 Million USD | 104.42% |
| 2013 Q1 | 32.68 Million USD | 60.99% |
| 2013 FY | 67 Million USD | 230.06% |
| 2012 FY | 20.3 Million USD | -24.4% |
| 2012 Q4 | 20.3 Million USD | 3.2% |
| 2012 Q3 | 19.67 Million USD | -9.46% |
| 2012 Q2 | 21.72 Million USD | -19.04% |
| 2012 Q1 | 26.83 Million USD | -0.07% |
| 2011 Q2 | 27.89 Million USD | -6.67% |
| 2011 Q1 | 29.88 Million USD | 15.48% |
| 2011 Q4 | 26.85 Million USD | -1.55% |
| 2011 Q3 | 27.27 Million USD | -2.21% |
| 2011 FY | 26.85 Million USD | 3.76% |
| 2010 FY | 25.88 Million USD | -90.7% |
| 2010 Q3 | 403.23 Million USD | 1799.46% |
| 2010 Q2 | 21.22 Million USD | 0.0% |
| 2010 Q4 | 25.88 Million USD | -93.58% |
| 2009 FY | 278.22 Million USD | 34.73% |
| 2009 Q4 | 278.22 Million USD | 0.0% |
| 2008 FY | 206.49 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -1938.297% |
| BrainsWay Ltd. | 15.31 Million USD | -6721.921% |
| Cerus Corporation | 144.3 Million USD | -623.964% |
| Envoy Medical, Inc. | 9.4 Million USD | -11011.561% |
| electroCore, Inc. | 8.94 Million USD | -11579.251% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -19456.514% |
| IceCure Medical Ltd | 4.24 Million USD | -24498.752% |
| Inogen, Inc. | 121.38 Million USD | -760.679% |
| OrthoPediatrics Corp. | 72.56 Million USD | -1339.767% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -3431.689% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -32732.423% |
| MaxCyte, Inc. | 36.1 Million USD | -2793.37% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -56434.626% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -245551.463% |
| Orthofix Medical Inc. | 326.58 Million USD | -219.889% |
| PAVmed Inc | 57.13 Million USD | -1728.428% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -4002.851% |
| RxSight, Inc. | 22.18 Million USD | -4608.441% |
| Sight Sciences, Inc. | 46.43 Million USD | -2149.782% |
| SI-BONE, Inc. | 61.05 Million USD | -1611.235% |
| TELA Bio, Inc. | 59.16 Million USD | -1665.695% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -816.661% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -10024.13% |
| Acutus Medical, Inc. | 54.83 Million USD | -1805.048% |
| Talis Biomedical Corporation | 29.22 Million USD | -3474.832% |
| Spectral AI, Inc. | 12.4 Million USD | -8324.393% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -4415.903% |
| CVRx, Inc. | 39.28 Million USD | -2559.511% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -8636.429% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -42904.528% |
| Bioventus Inc. | 589.79 Million USD | -77.132% |
| Venus Concept Inc. | 107.1 Million USD | -875.425% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -1922.161% |
| LivaNova PLC | 1.15 Billion USD | 9.308% |
| 908 Devices Inc. | 37.49 Million USD | -2686.634% |
| Alphatec Holdings, Inc. | 703.48 Million USD | -48.504% |
| Nemaura Medical Inc. | 26.37 Million USD | -3860.617% |
| NeuroPace, Inc. | 86.99 Million USD | -1100.856% |
| LENSAR, Inc. | 22.4 Million USD | -4562.006% |
| Apyx Medical Corporation | 52.31 Million USD | -1896.844% |
| Cutera, Inc. | 518.12 Million USD | -101.634% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -3462.156% |
| BioSig Technologies, Inc. | 4.68 Million USD | -22199.018% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -1689.897% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -4761.825% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 52.386% |
| Axonics, Inc. | 82.35 Million USD | -1168.482% |
| Outset Medical, Inc. | 190.91 Million USD | -447.212% |
| IRIDEX Corporation | 24.91 Million USD | -4093.261% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -742.745% |
| IRadimed Corporation | 20.73 Million USD | -4938.157% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -62307.945% |
| INVO Bioscience, Inc. | 19.99 Million USD | -5124.861% |
| Telesis Bio, Inc. | 40.87 Million USD | -2455.988% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -2461.175% |
| Varex Imaging Corporation | 668.6 Million USD | -56.253% |
| Quipt Home Medical Corp. | 136.29 Million USD | -666.517% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -29147.172% |
| Pulmonx Corporation | 60.63 Million USD | -1622.919% |
| Dynatronics Corporation | 11.78 Million USD | -8768.411% |
| Modular Medical, Inc. | 2.27 Million USD | -45881.91% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -25606.422% |
| Semler Scientific, Inc. | 6.27 Million USD | -16562.026% |
| InMode Ltd. | 75.91 Million USD | -1276.174% |
| Bruker Corporation | 2.83 Billion USD | 63.17% |
| Cytosorbents Corporation | 29.98 Million USD | -3384.051% |
| DexCom, Inc. | 4.19 Billion USD | 75.102% |
| Align Technology, Inc. | 2.45 Billion USD | 57.418% |
| Viveve Medical, Inc. | 10.84 Million USD | -9531.317% |
| ZimVie Inc. | 795.85 Million USD | -31.269% |
| Movano Inc. | 5.97 Million USD | -17393.453% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -898.718% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -245551.463% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -8636.429% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | -63.485% |
| Profound Medical Corp. | 12.66 Million USD | -8148.225% |
| Insulet Corporation | 1.85 Billion USD | 43.697% |
| enVVeno Medical Corporation | 2.43 Million USD | -42803.86% |
| Surmodics, Inc. | 65.82 Million USD | -1487.149% |
| iCAD, Inc. | 8 Million USD | -12957.232% |
| Nuwellis, Inc. | 6.78 Million USD | -15308.687% |
| Biotricity, Inc. | 35.91 Million USD | -2808.478% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -368.381% |
| Aethlon Medical, Inc. | 2.47 Million USD | -42031.309% |
| InspireMD, Inc. | 8.14 Million USD | -12731.112% |
| PAVmed Inc. | 57.13 Million USD | -1728.428% |
| BIOLASE, Inc. | 35.34 Million USD | -2855.497% |
| Beyond Air, Inc. | 29.77 Million USD | -3408.678% |
| FONAR Corporation | 57.45 Million USD | -1718.227% |
| AxoGen, Inc. | 101.16 Million USD | -932.709% |
| Vivani Medical, Inc. | 25.03 Million USD | -4072.827% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -1089.928% |
| Inari Medical, Inc. | 209.32 Million USD | -399.085% |
| UFP Technologies, Inc. | 118.04 Million USD | -785.009% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -8132.217% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -47695.007% |
| Tenon Medical, Inc. | 5.56 Million USD | -18666.104% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -58624.508% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -5824.363% |
| AdaptHealth Corp. | 3.15 Billion USD | 66.868% |
| Sintx Technologies, Inc. | 6.59 Million USD | -15745.73% |
| NanoVibronix, Inc. | 2.68 Million USD | -38794.602% |
| Quanterix Corporation | 78.08 Million USD | -1237.93% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -29147.172% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -21286.059% |
| TransMedics Group, Inc. | 568.84 Million USD | -83.654% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -6162.493% |
| NeuroMetrix, Inc. | 1.33 Million USD | -78265.478% |
| Hyperfine, Inc. | 9.8 Million USD | -10560.296% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -317.473% |
| Biomerica, Inc. | 2.66 Million USD | -39130.529% |
| Bone Biologics Corporation | 831.4 Thousand USD | -125556.301% |
| AVITA Medical, Inc. | 19.86 Million USD | -5158.937% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -52831.955% |
| Silk Road Medical, Inc | 114.15 Million USD | -815.143% |